You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Y ibritumomab

Showing 1 - 25 of 1,208
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GVHD, Leukemia, Lymphoma Trial in Duarte (biological, drug, procedure, radiation, other)

Active, not recruiting
  • Graft Versus Host Disease
  • +2 more
  • rituximab
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Lymphoma Trial in United Kingdom (biological, drug, radiation)

Terminated
  • Lymphoma
  • rituximab
  • +5 more
  • Manchester, England, United Kingdom
  • +4 more
Dec 16, 2021

Lymphoma Trial in Houston (Ibritumomab Tiuxetan (Zevalin), Rituximab)

Completed
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 30, 2022

Lymphoma, Follicular Trial in United States (Bendamustine, Rituximab, Y-90 ibritumomab)

Completed
Has Results
  • Lymphoma, Follicular
  • Scarborough, Maine
  • +3 more
Apr 27, 2021

Zevalin Post-marketing Surveillance in Japan

Completed
  • Non-Hodgkin's Lymphoma (NHL)
  • [90]Y-ibritumomab tiuxetan (Zevalin, BAY86-5128)
  • Multiple Locations, Japan
    (unnamed)
Sep 30, 2021

Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma, Ann Arbor Stage II Grade 1

Active, not recruiting
  • Ann Arbor Stage I Grade 1 Follicular Lymphoma
  • +9 more
  • Quality-of-Life Assessment
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 3, 2022

Non-Hodgkin's Lymphoma Trial in United States (Y-90-Zevalin, Moxtezafin Gadolinium, Rituximab)

Terminated
Has Results
  • Non-Hodgkin's Lymphoma
  • Berkeley, California
  • +8 more
Sep 6, 2021

Lymphoma Trial (biological, drug, procedure, radiation)

Completed
Has Results
  • Lymphoma
  • filgrastim
  • +4 more
  • (no location specified)
Jun 16, 2021

Follicular Lymphoma Trial in United States (Zevalin, Rituximab)

Terminated
Has Results
  • Follicular Lymphoma
  • Sun City, Arizona
  • +4 more
Sep 6, 2021

Primary CNS Non-Hodgkin Lymphoma Trial in Cleveland (rituximab, yttrium Y 90 ibritumomab tiuxetan)

Terminated
Has Results
  • Primary Central Nervous System Non-Hodgkin Lymphoma
  • rituximab
  • yttrium Y 90 ibritumomab tiuxetan
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 23, 2020

Lymphoma Trial in New York, Houston (biological, drug, radiation)

Completed
Has Results
  • Lymphoma
  • darbepoetin alfa
  • +8 more
  • New York, New York
  • +1 more
Oct 19, 2020

Lymphoma Trial in United States (biological, drug, radiation)

Completed
Has Results
  • Lymphoma
  • rituximab
  • +7 more
  • Anchorage, Alaska
  • +47 more
Dec 22, 2021

Lymphoma Trial in Spain (Rituximab, Ibritumomab tiuxetan)

Completed
  • Lymphoma
  • Alcorcón, Spain
  • +20 more
Apr 27, 2020

Follicular Lymphoma Trial in France, United Kingdom (90Y Ibritumomab tiuxetan, Rituximab)

Completed
  • Follicular Lymphoma
  • Lille, France
  • +6 more
Oct 11, 2019

Leukemia, Lymphoma Trial in Houston (Rituximab, 111In Ibritumomab, Planar Scintigraphy Imaging)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 23, 2020

Diffuse Large Cell Lymphoma, Lymphoma Trial in Houston (Zevalin, Carmustine, Etoposide)

Completed
Has Results
  • Diffuse Large Cell Lymphoma
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 12, 2021

Lymphoma Trial in Tucson (Methylprednisolone, Etoposide, Cytarabine)

Completed
Has Results
  • Lymphoma
  • Tucson, Arizona
    The University of Arizona Cancer Center
Aug 23, 2019

Lymphoma Trial in Atlanta, Chicago (rituximab, bortezomib, Ibritumomab tiuxetan)

Terminated
Has Results
  • Lymphoma
  • Atlanta, Georgia
  • +1 more
Aug 23, 2019

Relapsed Follicular Lymphoma Trial in Italy (ZEVALIN, BEAM)

Active, not recruiting
  • Relapsed Follicular Lymphoma
  • Genova, GE, Italy
  • +37 more
Dec 22, 2022

Lymphoma, Large Cell, Diffuse Trial in Worldwide (Zevalin)

Terminated
Has Results
  • Lymphoma, Large Cell, Diffuse
  • Mesa, Arizona
  • +89 more
Jan 17, 2022

Follicular Non-Hodgkin's Lymphoma Trial in Italy (R-CHOP or R-bendamustine, Observation, Maintenance weekly x4)

Active, not recruiting
  • Follicular Non-Hodgkin's Lymphoma
  • R-CHOP or R-bendamustine
  • +4 more
  • Meldola, Forlì Cesena, Italy
  • +47 more
Dec 29, 2021

Diffuse Large B-cell Lymphoma, Follicle Center Lymphoma Trial in Worldwide (Zevalin, Y-90-Zevalin, Rituximab)

Terminated
Has Results
  • Diffuse Large B-cell Lymphoma
  • Follicle Center Lymphoma
  • Casa Grande, Arizona
  • +92 more
Nov 18, 2021

Lymphoma Trial in Switzerland (ibritumomab tiuxetan, rituximab, melphalan)

Completed
  • Lymphoma
  • ibritumomab tiuxetan
  • +4 more
  • Aarau, Switzerland
  • +9 more
May 13, 2019

Lymphoma Trial in Duarte (biological, drug, procedure, radiation)

Completed
Has Results
  • Lymphoma
  • rituximab
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Jun 8, 2018

Acute Ischemic Stroke, Large Vessel Occlusion, Reperfusion Trial (Low-dose Y-6 sublingual tablets, High-dose Y-6 sublingual

Not yet recruiting
  • Acute Ischemic Stroke
  • +2 more
  • Low-dose Y-6 sublingual tablets
  • +4 more
  • (no location specified)
Nov 14, 2023